Literature DB >> 23063715

Neuroprotective effects of tanshinone IIA and/or tetramethylpyrazine in cerebral ischemic injury in vivo and in vitro.

Qiqiang Tang1, Ruodong Han, Han Xiao, Jilong Shen, Qingli Luo, Jun Li.   

Abstract

The present study compared the potential neuroprotective effects of tanshinone (Tan) IIA monotherapy, tetramethylpyrazine (TMP) monotherapy, and Tan IIA+TMP combination therapy in adult rat subjected to cerebral ischemic injury using the permanent middle cerebral artery occlusion (MCAO) model and in primary cortical neuron culture exposed to oxygen-glucose deprivation (OGD) model. Male Sprague Dawley rats (n=84) were randomly divided into sham-operated, MCAO, cmc-Na (sodium carboxymethyl cellulose), TMP, Tan IIA+TMP, and Tan IIA groups. In agreement with the in vivo experiment, primary cortical neuron culture was prepared from one-day-old SD rats and grouped according to exposure: normoxia control (NC), OGD, dimethyl sulfoxide, TMP, Tan IIA+TMP, and Tan IIA groups. The neurological deficits and infarct volume were evaluated at 24h after the MCAO models. Oxidative stress (malondialdehyde, glutathione, and superoxide dismutase) and intracellular [Ca(2+)](i) concentration were measured through spectrophotometric analysis. Neurocyte apoptosis and viability were respectively evaluated through terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, respectively. Apoptosis factors (Bax, Bcl-2, caspase-3, and trmp-7) were analyzed using western blot and immunohistochemistry. The results suggest that Tan IIA+TMP combination therapy was more effective than TMP monotherapy but not Tan IIA monotherapy. Tan IIA monotherapy is more effective than TMP monotherapy in protecting the neuron against hypoxia/ischemia both in vitro and in vivo. Interestingly, Tan IIA significantly increased the phosphorylation of AKT in primary cortical neuronal culture exposed to OGD, which was abolished by PI3K inhibitor LY294002. The PI3K/AKT signaling pathway may be involved in the neuroprotective mechanism of Tan IIA on primary cortical neurons.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23063715     DOI: 10.1016/j.brainres.2012.09.034

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  21 in total

1.  The Synergic Effect of Tetramethylpyrazine Phosphate and Borneol for Protecting Against Ischemia Injury in Cortex and Hippocampus Regions by Modulating Apoptosis and Autophagy.

Authors:  Bin Yu; Ming Ruan; Tao Liang; Shi-Wen Huang; Yun Yu; Hai-Bo Cheng; Xiang-Chun Shen
Journal:  J Mol Neurosci       Date:  2017-08-04       Impact factor: 3.444

2.  Neuroprotective Effect of 3-(Naphthalen-2-Yl(Propoxy)Methyl)Azetidine Hydrochloride on Brain Ischaemia/Reperfusion Injury.

Authors:  Eun-A Kim; Jung-Min Na; Jiae Kim; Soo Young Choi; Jee-Yin Ahn; Sung-Woo Cho
Journal:  J Neuroimmune Pharmacol       Date:  2017-02-28       Impact factor: 4.147

3.  MLC901 during sleep deprivation rescues fear memory disruption in rats.

Authors:  Mohammad Nasehi; Ameneh Mohammadi; Mohaddeseh Ebrahimi-Ghiri; Mehrdad Hashemi; Mohammad-Reza Zarrindast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-02-28       Impact factor: 3.000

4.  Tetramethylpyrazine phosphate and borneol combination therapy synergistically attenuated ischemia-reperfusion injury of the hypothalamus and striatum via regulation of apoptosis and autophagy in a rat model.

Authors:  Bin Yu; Ming Ruan; Tao Liang; Shi-Wen Huang; Sheng-Jin Liu; Hai-Bo Cheng; Xiang-Chun Shen
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 5.  Neuroprotective Phytochemicals in Experimental Ischemic Stroke: Mechanisms and Potential Clinical Applications.

Authors:  Hui Xu; Emily Wang; Feng Chen; Jianbo Xiao; Mingfu Wang
Journal:  Oxid Med Cell Longev       Date:  2021-04-28       Impact factor: 6.543

6.  Effects of Tetramethylpyrazine on Functional Recovery and Neuronal Dendritic Plasticity after Experimental Stroke.

Authors:  Jun-Bin Lin; Chan-Juan Zheng; Xuan Zhang; Juan Chen; Wei-Jing Liao; Qi Wan
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-26       Impact factor: 2.629

Review 7.  Ligustrazine monomer against cerebral ischemia/reperfusion injury.

Authors:  Hai-Jun Gao; Peng-Fei Liu; Pei-Wen Li; Zhuo-Yan Huang; Feng-Bo Yu; Ting Lei; Yong Chen; Ye Cheng; Qing-Chun Mu; Hai-Yan Huang
Journal:  Neural Regen Res       Date:  2015-05       Impact factor: 5.135

8.  Inhibition of the spinal astrocytic JNK/MCP-1 pathway activation correlates with the analgesic effects of tanshinone IIA sulfonate in neuropathic pain.

Authors:  Jun Tang; Chao Zhu; Zhi-hong Li; Xiao-yu Liu; Shu-kai Sun; Ting Zhang; Zhuo-jing Luo; Hui Zhang; Wei-yan Li
Journal:  J Neuroinflammation       Date:  2015-03-25       Impact factor: 8.322

9.  Protective Effect of Edaravone in Primary Cerebellar Granule Neurons against Iodoacetic Acid-Induced Cell Injury.

Authors:  Xinhua Zhou; Longjun Zhu; Liang Wang; Baojian Guo; Gaoxiao Zhang; Yewei Sun; Zaijun Zhang; Simon Ming-Yuen Lee; Pei Yu; Yuqiang Wang
Journal:  Oxid Med Cell Longev       Date:  2015-10-18       Impact factor: 6.543

10.  Neuroprotective effects of DAHP and Triptolide in focal cerebral ischemia via apoptosis inhibition and PI3K/Akt/mTOR pathway activation.

Authors:  Weiyun Li; Yang Yang; Zhiying Hu; Shucai Ling; Marong Fang
Journal:  Front Neuroanat       Date:  2015-04-22       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.